Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Invesco India ESG Integration Strategy Fund · Regular ✕HDFC Pharma and Healthcare Fund · Regular ✕

Growth of ₹10,000

Basics

Invesco India ESG Integration Strategy FundHDFC Pharma and Healthcare Fund
CategorySectoral / ThematicSectoral / Thematic
PlanRegularRegular
Fund houseInvescoHDFC
NAV₹17.9400₹22.8170
NAV date20 Nov 202620 Nov 2026
History5.7 years3.1 years
Expense ratio2.6%2.1%
Stars★★★★★★★★★★
Growth Score25.7093.90

Returns

Invesco India ESG Integration Strategy FundHDFC Pharma and Healthcare Fund
1 month+9.12%+12.87%
3 months+3.16%+6.85%
6 months+14.19%+17.20%
YTD+3.58%+32.43%
1 year+1.18%+30.73%
3 years (CAGR)+9.21%+29.16%
5 years (CAGR)+6.06%—
10 years (CAGR)——
Since launch+10.90%+30.28%

Risk

Invesco India ESG Integration Strategy FundHDFC Pharma and Healthcare Fund
Volatility16.2%15.8%
Downside volatility11.7%8.6%
Sharpe0.171.44
Sortino0.232.64
Calmar0.381.94
Return / risk0.571.85
Deepest fall−23.93%−15.07%
Days to recover—133
Below its high−5.03%+0.00%

Against benchmark

Invesco India ESG Integration Strategy FundHDFC Pharma and Healthcare Fund
Alpha—+6.36%
Beta—0.97
R²—85.0%
Up capture—106.7%
Down capture—74.4%
Tracking error—6.1%
Information ratio—0.97
Treynor—0.22

Consistency

Invesco India ESG Integration Strategy FundHDFC Pharma and Healthcare Fund
Best 1-year+40.55%+64.96%
Middle 1-year+4.34%+21.84%
Worst 1-year−14.22%+0.52%
1-year periods with a loss40.5%0.0%
Middle 3-year+12.22%+28.68%
Positive months63.9%69.4%
Best day+4.20%+3.19%
Worst day−5.49%−3.62%
Worst 5% day−1.45%−1.50%
Positive days52.2%58.1%
NAVs a year247247

SIP of ₹10,000 a month

Invesco India ESG Integration Strategy FundHDFC Pharma and Healthcare Fund
5-year XIRR+8.24%—
5-year value₹7,41,706—
3-year XIRR+5.38%+26.26%
1-year XIRR+14.49%+39.84%

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth